Background: There is only limited experience with wearable cardioverter-defibrillators (WCD) in pediatric patients. We report on the successful application of a WCD in an adolescent patient with hypertrophic cardiomyopathy and myocardial bridging. Case presentation: A 15-year-old girl presented with a history of recurrent syncope, dyspnea, and vertigo with exercise. Diagnostic work-up revealed non-obstructive hypertrophic cardiomyopathy and signs of myocardial ischemia with exercise. Given this high-risk constellation, the patient was scheduled for prophylactic implantation of an implantable cardioverter-defibrillator (ICD). One month after initial presentation and days prior to the planned ICD implantation, the patient collapsed during ...
AIMS: This study was designed to prospectively evaluate the risk-benefit ratio of implantable cardi...
International audienceBackgroundCalmodulinopathy is an emerging group of primary electrical disease ...
Background: Hypertrophic cardiomyopathy is a genetic disease associated with a risk of ventricular t...
Hypertrophic cardiomyopathy; Myectomy; Sudden cardiac deathMiocardiopatia hipertròfica; Miectomia; M...
Objectives The aim of this study was to determine the efficacy of implantable cardioverter-defibrill...
Contains fulltext : 47626reimer.pdf (publisher's version ) (Closed access)To evalu...
The identification of high-risk patients with hypertrophic cardiomyopathy (HC) for primary preventio...
Objectives: This study examined the indications, efficacy and outcomes of implantable cardioverter d...
Background. During the past decade. the implantable cardioverter-defibrillator (ICD) has emerged as ...
INTRODUCTION: Experience in endovascular/endocardial techniques for implanting implantable cardiover...
AbstractHypertrophic cardiomyopathy’s (HCM) association with sudden cardiac death is well recognised...
Introduction: The implantation of a cardioverter-defibrillator (ICD) is an established method of sud...
Abstract. Objectives: This study examined the indicat-ions, efficacy and outcomes of implantable car...
AIMS: This study was designed to prospectively evaluate the risk-benefit ratio of implantable cardi...
International audienceBackgroundCalmodulinopathy is an emerging group of primary electrical disease ...
Background: Hypertrophic cardiomyopathy is a genetic disease associated with a risk of ventricular t...
Hypertrophic cardiomyopathy; Myectomy; Sudden cardiac deathMiocardiopatia hipertròfica; Miectomia; M...
Objectives The aim of this study was to determine the efficacy of implantable cardioverter-defibrill...
Contains fulltext : 47626reimer.pdf (publisher's version ) (Closed access)To evalu...
The identification of high-risk patients with hypertrophic cardiomyopathy (HC) for primary preventio...
Objectives: This study examined the indications, efficacy and outcomes of implantable cardioverter d...
Background. During the past decade. the implantable cardioverter-defibrillator (ICD) has emerged as ...
INTRODUCTION: Experience in endovascular/endocardial techniques for implanting implantable cardiover...
AbstractHypertrophic cardiomyopathy’s (HCM) association with sudden cardiac death is well recognised...
Introduction: The implantation of a cardioverter-defibrillator (ICD) is an established method of sud...
Abstract. Objectives: This study examined the indicat-ions, efficacy and outcomes of implantable car...
AIMS: This study was designed to prospectively evaluate the risk-benefit ratio of implantable cardi...
International audienceBackgroundCalmodulinopathy is an emerging group of primary electrical disease ...
Background: Hypertrophic cardiomyopathy is a genetic disease associated with a risk of ventricular t...